The narrative details the paradigm shift brought by GLP-1 medications, including liraglutide and semaglutide, which offer improved cardiovascular outcomes and significant health benefits
GIP, in addition to GLP-1, enhances insulin release after meals, reduces hunger, and increases fat metabolism
Tirzepatide came off the shortage list in December 2024 and semaglutide followed in February 2025
Patients, athletes, healthcare workers and others use sterile solutions to help in medication delivery, injections, irrigation and other uses
For detailed information on choosing the right magnesium form during GLP-1 treatment, see our article on best magnesium forms for Ozempic users